Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about edit
Recent news which mentions edit
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Editas Medicine Stock Was Skyrocketing This Week
August 15, 2025
Tickers
EDIT
Tags
Recent Press Releases
EDIT
Market News
From
Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 13, 2025
Tickers
ARCT
DERM
EDIT
GBIO
Tags
ZVRA
RSLS
EDIT
From
Benzinga
Can This Beaten-Down Stock Bounce Back?
August 12, 2025
Tickers
EDIT
Tags
EDIT
Recent Press Releases
Market News
From
Motley Fool
Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now?
June 28, 2025
Tickers
EDIT
Tags
Market News
EDIT
Recent Press Releases
From
Motley Fool
2 Beaten-Down Stocks to Avoid
June 27, 2025
Tickers
EDIT
SRPT
Tags
Market News
SRPT
Recent Press Releases
From
Motley Fool
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
June 18, 2025
Tickers
BEAM
CRSP
EDIT
LLY
Tags
EDIT
LLY
CRSP
From
Benzinga
Editas Medicine Is Great. Here's Why You Shouldn't Buy It.
June 17, 2025
Tickers
EDIT
Tags
Market News
EDIT
Recent Press Releases
From
Motley Fool
1 Stock Down 97% That Could Double, According to Wall Street
May 25, 2025
Tickers
EDIT
Tags
Market News
EDIT
Recent Press Releases
From
Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 21, 2025
Tickers
AHG
AKYA
BDSX
BEAT
Tags
IVF
BZI/TFM
Benzinga
From
Benzinga
Editas Medicine: A Cautionary Tale for Investors
May 15, 2025
Tickers
EDIT
Tags
Recent Press Releases
EDIT
Market News
From
Motley Fool
Earnings Scheduled For May 12, 2025
May 12, 2025
Tickers
ACHC
ACHR
ACNT
ADV
Tags
CHGG
DVA
PET
From
Benzinga
Earnings Scheduled For March 5, 2025
March 05, 2025
Tickers
ACR
ALNT
ALTG
ALTO
Tags
LPSN
GRND
VET
From
Benzinga
Peering Into Editas Medicine's Recent Short Interest
February 25, 2025
Tickers
EDIT
Tags
Short Sellers
EDIT
Trading Ideas
From
Benzinga
JPMorgan Downgrades Editas Medicine, Says Focus Shift Sparks Investor Caution
December 17, 2024
Tickers
EDIT
NEWS
Tags
Stories That Matter
Analyst Color
Benzinga
From
Benzinga
Walmart To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Friday
December 13, 2024
Tickers
AES
AVGO
CIEN
DHI
Tags
MTH
AVGO
Analyst Ratings
From
Benzinga
This Toll Brothers Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
December 13, 2024
Tickers
EDIT
NDSN
NEWS
RNG
Tags
NDSN
Markets
Trading Ideas
From
Benzinga
Editas Medicine Realigns Strategy to Focus on In Vivo Gene Editing, Targets Human Proof Of Concept By 2026
December 13, 2024
Tickers
EDIT
NEWS
Tags
Top Stories
General
Benzinga
From
Benzinga
12 Analysts Have This To Say About Editas Medicine
December 11, 2024
Tickers
EDIT
Tags
EDIT
Analyst Ratings
Benzinga
From
Benzinga
Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts
November 25, 2024
Tickers
BEAM
CRSP
EDIT
NEWS
Tags
SHL
Downgrades
Expert Ideas
From
Benzinga
Expert Outlook: Editas Medicine Through The Eyes Of 7 Analysts
October 23, 2024
Tickers
EDIT
Tags
EDIT
BZI/AAR
Analyst Ratings
From
Benzinga
Where Editas Medicine Stands With Analysts
September 17, 2024
Tickers
EDIT
Tags
BZI/AAR
Benzinga
Market News
From
Benzinga
Looking for Stock Bargains With Room to Run? Try This.
September 11, 2024
Tickers
AAPL
AMZN
BJRI
CBRL
Tags
WBA
Market News
SABR
From
Motley Fool
Boot Barn To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday
August 08, 2024
Tickers
BMBL
BOOT
CENTA
CRL
Tags
analyst forecasts
BOOT
Pre/Market Outlook
From
Benzinga
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
July 17, 2024
Tickers
CRSP
EDIT
NTLA
Tags
NTLA
Market News
Stocks to Buy
From
InvestorPlace
3 Profitable CRISPR Stocks Earning Analysts’ Praise
July 09, 2024
Tickers
CRSP
EDIT
NTLA
Tags
Stocks to Buy
EDIT
CRSP
From
InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
July 08, 2024
Tickers
CRSP
EDIT
GNOM
ILMN
Tags
NTLA
NTRA
EDIT
From
InvestorPlace
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
June 26, 2024
Tickers
CRSP
EDIT
NLTA
Tags
NASDAQ:CRSP,NASDAQ:EDIT,NASDAQ:NLTA
Market News
Stocks to Buy
From
InvestorPlace
3 Gene Editing Stocks That Could Make Your Grandchildren Rich
June 25, 2024
Tickers
CRSP
EDIT
NTLA
Tags
Stocks to Buy
EDIT
NASDAQ:CRSP,NASDAQ:EDIT,NASDAQ:NTLA
From
InvestorPlace
Unveiling 5 Analyst Insights On Editas Medicine
June 18, 2024
Tickers
EDIT
Tags
EDIT
BZI/AAR
Analyst Ratings
From
Benzinga
The Analyst Verdict: Editas Medicine In The Eyes Of 4 Experts
May 30, 2024
Tickers
EDIT
Tags
BZI/AAR
Analyst Ratings
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.